Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference11 articles.
1. Concordet D, Gandia P, Montastruc JL, Bousquet-Melou A, Lees P, Ferran A, et al. Levothyrox® new and old formulations: are they switchable for millions of patients? Clin Pharmacokinet. 2019;58(7):827–33.
2. Food and Drug Administration. Guidance for industry: Average, population, and individual approaches to establishing bioequivalence. Rockville: U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER); 1999.
3. Food and Drug Administration. In vivo bioequivalence studies based on population and individual bioequivalence approaches. Rockville: U.S. Department of Health and Human Services FDA, Center for Drug Evaluation and Research (CDER); 1997.
4. Chow S-C. Individual bioequivalence-a review of FDA draft guidance. Drug Inf J. 1999;33(2):435–44.
5. Hsuan FC. Some statistical considerations on the FDA draft guidance for individual bioequivalence. Stat Med. 2000;19(20):2879–84.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献